BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Regulus Therapeutics, Inc. (RGLS) Announces Timing For First Quarter 2015 Financial Results Webcast And Conference Call 5/1/2015 8:08:07 AM
Regulus Therapeutics, Inc. (RGLS) To Present At The Deutsche Bank (DB) 40th Annual Healthcare Conference 4/30/2015 11:48:16 AM
Regulus Therapeutics, Inc. (RGLS) To Present Late-Breaking, Expanded RG-101 Data Set For The Treatment Of HCV At The International Liver Congress 2015 (ILC 2015) 4/9/2015 8:06:03 AM
Regulus Therapeutics, Inc. (RGLS) Release: RG-125 (AZD4076), A microRNA Therapeutic Targeting Microrna-103/107 For The Treatment Of NASH In Patients With Type 2 Diabetes/Pre-Diabetes, Selected As Clinical Candidate By Astrazeneca 4/8/2015 6:44:04 AM
Regulus Therapeutics, Inc. (RGLS) Receives Orphan Medicinal Product Designation From The European Commission (EC) For RG-012, A Microrna Therapeutic In Development For The Treatment Of Alport Syndrome 3/25/2015 6:43:15 AM
Regulus Therapeutics, Inc. (RGLS) To Present At Cowen and Company 35th Annual Healthcare Conference 2/27/2015 9:42:49 AM
Regulus Therapeutics, Inc. (RGLS) To Present At 2015 RBC Capital Markets' Healthcare Conference 2/20/2015 8:42:34 AM
Regulus Therapeutics, Inc. (RGLS) Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights 2/19/2015 11:46:04 AM
Regulus Therapeutics, Inc. (RGLS) Announces Timing For Fourth Quarter And Year-End 2014 Financial Results Webcast And Conference Call 2/13/2015 6:56:47 AM
Regulus Therapeutics, Inc. (RGLS) To Ring The Nasdaq Stock Market Closing Bell 2/9/2015 9:47:10 AM
12345678910...